Related Experiment Video

Updated: Jun 7, 2026

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds
09:29

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds

Published on: October 29, 2015

Strategies for antiviral screening targeting early steps of virus infection

Tao Peng1

  • 1State Key Laboratory of Respiratory Diseases, Guangzhou Institute of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, 510530, China. peng_tao@gibh.ac.cn

Virologica Sinica
|October 21, 2010
PubMed

Insights

Viral entry into host cells is a critical step for infection and a key target for antiviral drugs. This review examines the mechanisms of viral attachment and entry for Herpes Simplex Virus, Hepatitis C Virus, and Enterovirus 71.

Area of Science:

  • Virology
  • Molecular Biology
  • Drug Discovery

Background:

  • Viral infection initiates with cell entry and replication, making the virus entry machinery a prime target for antiviral therapeutics.
  • The early stages of the viral life cycle, including attachment and entry, dictate tropism, replication, and disease outcomes.
  • Understanding these early steps is crucial for developing effective antiviral strategies.

Purpose of the Study:

  • To review the mechanistic understanding of viral attachment and entry processes.
  • To summarize strategies for antagonist screening targeting viral entry.
  • To use Herpes Simplex Virus (HSV), Hepatitis C Virus (HCV), and Human Enterovirus 71 (EV71) as representative examples.

Main Methods:

  • Review of current literature on viral entry mechanisms.
  • Comparative analysis of enveloped DNA (HSV), enveloped RNA (HCV), and non-enveloped (EV71) viruses.
  • Summary of antagonist screening methodologies.

Main Results:

  • Detailed mechanistic insights into the attachment and entry processes of HSV, HCV, and EV71.
  • Identification of key viral and host factors involved in these early steps.
  • Overview of established and emerging strategies for developing entry inhibitors.

Conclusions:

  • Viral entry mechanisms are diverse but represent a significant vulnerability for therapeutic intervention.
  • Targeting viral attachment and entry is a promising avenue for novel antiviral drug development.
  • Further research into these processes will facilitate the design of broad-spectrum antiviral agents.

More Related Videos

High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses11:34

High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses

Published on: May 5, 2014

Use of Viral Entry Assays and Molecular Docking Analysis for the Identification of Antiviral Candidates against Coxsackievirus A1606:03

Use of Viral Entry Assays and Molecular Docking Analysis for the Identification of Antiviral Candidates against Coxsackievirus A16

Published on: July 15, 2019

Related Concept Videos

Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...